PLUXEE

Pluxee reported third-quarter 2026 revenue of €312m, well above the analyst consensus of €299m and the most optimistic individual forecast of €306m. Organic revenue fell 3.3%, but was better than expected (-4.3%). Effects of the PAT reform in Brazil were smaller than feared, and the company confirmed its full-year targets (stable comparable revenues and a slight organic increase in the recurring EBITDA margin). As a result, the share price rose by around 6% and reached €12.64 intraday. » Mere på de.investing.com

Pluxee reports total revenue of €308m for Q1 2026 and organic revenue growth of 9%, driven by the employee-benefits segment. The company confirmed its full-year targets but presented them in two scenarios, as the PAT reform in Brazil could cause revenue declines in Brazil of up to 40% in H2 2026 and up to 50% by 2027. Pluxee is responding with operational measures, renegotiations, legal steps and the introduction of open-loop solutions, and is continuing its M&A strategy (acquisitions of Skipr, ProEves) as well as securing major contracts in Italy and Mexico. The share price rose 6.19% to €13.73 after the results were published. » Mere på de.investing.com

Pluxee recorded revenue of €308m in Q1 2026 and organic growth of 9%; operating revenue rose to €268m (+9.1%). The stock jumped 6.19% premarket to €13.73 after the figures. Strategic acquisitions and regional tenders contributed to the growth, and management confirmed the 2026 financial targets with a goal of a higher EBITDA margin and 80% cash conversion. However, risks were noted, in particular an expected revenue decline in Brazil of around 40% in H2 2026 (up to 50% by 2027) and possible delays on contracts in Romania. » Mere på de.investing.com